- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Thrombopoietin receptor,
Total 17520 results
-
Shanghai Juncell TherapeuticsShanghai 10th People's HospitalRecruitingAdvanced Gynecologic Tumors | Signal Switch Receptor Modified TIL | Treatment Side Effects | Effects of ImmunotherapyChina
-
National Cancer Institute (NCI)TerminatedPapillomavirus Infections | Oropharyngeal NeoplasmsUnited States
-
Corcept TherapeuticsCompletedHealthy AdultsNetherlands
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
NeuShen TherapeuticsRecruiting
-
National Cancer Institute (NCI)CompletedLymphoma, T-Cell, Cutaneous | Leukemia, T-CellUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Withdrawn
-
Rahul AggarwalJanssen Scientific Affairs, LLCActive, not recruitingProstate Cancer | Small Cell Carcinoma | Small Cell Neuroendocrine CarcinomaUnited States
-
Washington University School of MedicineCompleted
-
Emory UniversityNational Cancer Institute (NCI); Pfizer; National Institutes of Health (NIH)CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Metastatic Breast CarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Prospect Creek FoundationCompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Hebrew SeniorLifeActive, not recruiting
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Estrogen Receptor | Her-2 | Pgr
-
SanofiCompletedMajor Depressive DisorderUnited States
-
Astex Pharmaceuticals, Inc.TerminatedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Clinical SolutionsCompletedHIV Infections | Sarcoma, KaposiUnited States
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Ellipses PharmaRecruitingMetastatic Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States, Spain, United Kingdom
-
Seattle Children's HospitalActive, not recruitingGlioma | Ependymoma | Medulloblastoma | Pineoblastoma | Central Nervous System Tumor, Pediatric | Germ Cell Tumor | Atypical Teratoid/Rhabdoid Tumor | Primitive Neuroectodermal Tumor | Choroid Plexus CarcinomaUnited States
-
Seattle Children's HospitalActive, not recruitingGlioma | Ependymoma | Medulloblastoma | Pineoblastoma | Central Nervous System Tumor, Pediatric | Germ Cell Tumor | Atypical Teratoid/Rhabdoid Tumor | Primitive Neuroectodermal Tumor | Choroid Plexus CarcinomaUnited States
-
Chang Gung Memorial HospitalRecruiting
-
Corcept TherapeuticsCompleted
-
Merck Sharp & Dohme LLCCompletedChemotherapy-Induced Nausea and Vomiting (CINV)
-
Shenzhen Pregene Biopharma Co., Ltd.Recruiting
-
Seattle Children's HospitalRecruitingGlioma | Ependymoma | Medulloblastoma, Childhood | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma | Central Nervous System Tumor | Germ Cell Tumor | Atypical Teratoid/Rhabdoid Tumor | Primitive Neuroectodermal Tumor | Choroid Plexus Carcinoma | Pineoblastoma, ChildhoodUnited States
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Sir Run Run Shaw HospitalCompleted
-
Massachusetts General HospitalExelixisActive, not recruitingBreast CancerUnited States
-
Jose Pablo LeoneEli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC)RecruitingMale Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Negative Breast CarcinomaUnited States
-
Indiana UniversityTranslational Breast Cancer Research ConsortiumCompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Fundacion Clinic per a la Recerca BiomédicaHospital Sant Joan de DeuRecruitingAnti-NMDA Receptor EncephalitisSpain
-
Brown UniversityCures Within Reach; Lifespan; Legorreta Cancer Center at Brown UniversityRecruitingUrothelial Carcinoma Bladder | Androgen Receptor PositiveUnited States
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Turku University HospitalActive, not recruiting
-
Second Affiliated Hospital of Soochow UniversitySoochow T-Maximun Biotechnology Co. LTDRecruitingAdvanced Glioma | Complication of Chimeric Antigen Receptor (CAR-T) Cell TherapyChina
-
North Eastern German Society of Gynaecological...Center for Clinical Trials Philipps University MarburgActive, not recruitingEstrogen Receptor Positive Tumor | Primary Invasive Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative TumorGermany, Switzerland
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States
-
Institut Català d'OncologiaAmgenActive, not recruitingStage I Breast Cancer | Breast Neoplasm Female | Stage II Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative NeoplasmSpain
-
National Cancer Institute (NCI)CompletedBreast Cancer | Breast Neoplasms | Adenocarcinomas | Metastatic Solid Tumors Characterized by HER2/Neu ExpressionUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast AdenocarcinomaUnited States, Canada
-
Northwestern UniversityNational Cancer Institute (NCI); AmgenTerminatedStage IV Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Breast Carcinoma Metastatic in the Bone | Circulating Tumor Cell CountUnited States
-
Tongji HospitalRecruitingBreast Cancer | TNBC - Triple-Negative Breast Cancer | Estrogen-receptor-negative Breast CancerChina
-
University Health Network, TorontoSuspendedLung Transplant RecipientCanada
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
ActelionCompletedHypertension, PulmonaryTaiwan, Korea, Republic of, Belarus, India, Romania, Ukraine
-
Baylor College of MedicineThe Methodist Hospital Research InstituteWithdrawnClassical Hodgkin Lymphoma | Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedType 2 DiabetesChina
-
Northwestern UniversityNational Cancer Institute (NCI)Not yet recruitingMetastatic Breast Cancer | Estrogen-receptor-positive Breast Cancer | HER2/Neu-Negative Breast Cancer | Advanced Breast CancervUnited States
-
University Hospital of FerraraRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide Therapy (PRRT)Italy